Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Garland, M.
Right arrow Articles by Willett, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garland, M.
Right arrow Articles by Willett, W. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 147, No. 7: 636-643
Copyright © 1998 by The Johns Hopkins University School of Hygiene and Public Health


other

Menstrual Cycle Characteristics and History of Ovulatory Infertility in Relation to Breast Cancer Risk in a Large Cohort of US Women

Miriam Garland1, David J. Hunter1,2,3,, Graham A. Colditz1,2,3, JoAnn E. Manson1,2,4, Meir J. Stampfer1,2,5, Donna Spiegelman1,6, Frank Speizer2 and Walter C. Willett1,2,5

1 Department of Epidemiology, Harvard School of Public Health Boston, MA
2 Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital Boston, MA
3 Harvard Center for Cancer Prevention, Harvard School of Public Health Boston, MA
4 Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School Boston, MA
5 Department of Nutrition, Harvard School of Public Health Boston, MA
6 Department of Biostatistics, Harvard School of Public Health Boston, MA

Reprint requests to Dr. David Hunter, Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115.

Menstrual cycle characteristics and ovulatory infertility were evaluated in relation to breast cancer risk among 116,678 women in the Nurses' Health Study II, a prospective cohort study of female registered nurses who were aged 25–42 years and living in 14 US states at enrollment in 1989. During 396,299 person-years of follow-up between return of the baseline questionnaire and June 1993, 251 cases of breast cancer were identified in this cohort. The multivariate relative risk (RR) associated with age at menarche >13 years compared with age ≤12 years was 0.66 (95% confidence interval (CI) 0.44–0.99). Short and long menstrual cycle lengths at ages 18–22 years were associated with reduced risk. Compared with menstrual cycle length 26–31 days, the multivariate relative risks (95% CIs) for more extreme cycle lengths were: <26 days, 0.50 (0.25–0.98); 32–39 days, 0.81 (0.51–1.28); and >39 days or too irregular for estimation of a usual cycle length, 0.41 (0.18–0.94). The multivariate relative risk associated with a history of ovulatory infertility, compared with no such history, was 0.41 (95% CI 0.18–0.93). These results are consistent with the hypothesis that reduced exposure to ovulatory menstrual cycles provides a protective effect against breast cancer. Am J Epidemiol 1998; 147: 636–43.

breast neoplasms; infertility, female; menstrual cycle; menstruation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. L. Sprague, A. Trentham-Dietz, M. B. Terry, H. B. Nichols, A. J. Bersch, and D. S.M. Buist
Fertility Drug Use and Mammographic Breast Density in a Mammography Screening Cohort of Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3128 - 3133.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Jensen, H. Sharif, J. H. Olsen, and S. K. Kjaer
Risk of Breast Cancer and Gynecologic Cancers in a Large Population of Nearly 50,000 Infertile Danish Women
Am. J. Epidemiol., July 1, 2008; 168(1): 49 - 57.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Jensen, H. Sharif, E. I. Svare, K. Frederiksen, and S. K. Kjaer
Risk of Breast Cancer After Exposure to Fertility Drugs: Results from a Large Danish Cohort Study
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1400 - 1407.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. L. Terry, W. C. Willett, J. W. Rich-Edwards, and K. B. Michels
A Prospective Study of Infertility Due to Ovulatory Disorders, Ovulation Induction, and Incidence of Breast Cancer
Arch Intern Med, December 11, 2006; 166(22): 2484 - 2489.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. L. Terry, W. C. Willett, J. W. Rich-Edwards, D. J. Hunter, and K. B. Michels
Menstrual Cycle Characteristics and Incidence of Premenopausal Breast Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1509 - 1513.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
L Hilakivi-Clarke, C Wang, M Kalil, R Riggins, and R G Pestell
Nutritional modulation of the cell cycle and breast cancer
Endocr. Relat. Cancer, December 1, 2004; 11(4): 603 - 622.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Gauthier, X. Paoletti, F. Clavel-Chapelon, and and the E3N group
Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study
Hum. Reprod., October 1, 2004; 19(10): 2216 - 2221.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. A. Brinton, B. Scoccia, K. S. Moghissi, C. L. Westhoff, M. D. Althuis, J. E. Mabie, and E. J. Lamb
Breast cancer risk associated with ovulation-stimulating drugs
Hum. Reprod., September 1, 2004; 19(9): 2005 - 2013.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Cabanes, M. Wang, S. Olivo, S. DeAssis, J.-A. Gustafsson, G. Khan, and L. Hilakivi-Clarke
Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis
Carcinogenesis, May 1, 2004; 25(5): 741 - 748.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. M. Biro, W. F. Anderson, A. S. Hamilton, and T. M. Mack
Puberty and Genetic Susceptibility to Breast Cancer
N. Engl. J. Med., September 11, 2003; 349(11): 1088 - 1089.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Must, S.M. Phillips, E.N. Naumova, M. Blum, S. Harris, B. Dawson-Hughes, and W. M. Rand
Recall of Early Menstrual History and Menarcheal Body Size: After 30 Years, How Well Do Women Remember?
Am. J. Epidemiol., April 1, 2002; 155(7): 672 - 679.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Clavel-Chapelon
Evolution of age at menarche and at onset of regular cycling in a large cohort of French women
Hum. Reprod., January 1, 2002; 17(1): 228 - 232.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
P. A. van den Brandt, D. Spiegelman, S.-S. Yaun, H.-O. Adami, L. Beeson, A. R. Folsom, G. Fraser, R. A. Goldbohm, S. Graham, L. Kushi, et al.
Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer Risk
Am. J. Epidemiol., September 15, 2000; 152(6): 514 - 527.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Hilakivi-Clarke
Estrogens, BRCA1, and Breast Cancer
Cancer Res., September 1, 2000; 60(18): 4993 - 5001.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
S.D. Harlow, D.D. Baird, C.R. Weinberg, and A.J. Wilcox
Urinary oestrogen patterns in long follicular phases
Hum. Reprod., January 1, 2000; 15(1): 11 - 16.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Ricci, F. Parazzini, E. Negri, S. Marsico, and C. La Vecchia
Fertility drugs and the risk of breast cancer
Hum. Reprod., June 1, 1999; 14(6): 1653 - 1655.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.